A Zydus Cadila News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from A zydus cadila. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In A Zydus Cadila Today - Breaking & Trending Today
Increasing Production Of Remdesivir To Meet Demand: Pharma Firms In view of increased demand for the medicine due to a spike in Covid-19 cases, the government on Sunday prohibited the export of Remdesivir injection. AP Outlook Web Bureau 2021-04-14T16:56:41+05:30 Increasing Production Of Remdesivir To Meet Demand: Pharma Firms outlookindia.com 2021-04-14T16:58:20+05:30 Also read Several manufacturers of Remdesivir a drug that is considered important in the treatment of Covid-19 said they have ramped up production of the drug to meet its rising demand across the country. In view of increased demand for the medicine due to a spike in Covid-19 cases, the government on Sunday prohibited the export of Remdesivir injection and its active pharmaceutical ingredients (API) till the situation in the country improves. ....
Synopsis A Zydus Cadila spokesperson said, The current spike in COVID-19 cases has led to a higher demand of Remdesivir. We are currently producing Remdesivir at three of our facilities. To cater to the demand we have ramped up our production from the earlier 5-6 lakh vials a month to 10-12 lakh vials a month, which we will scale towards 20 lakh vials a month. Explained: Why the sudden shortage of Remdesivir and the way forward Several manufacturers of Remdesivir, that is being used in treatment of COVID-19, said they have ramped up production of the drug to meet its rising demand across the country. In view of increased demand for the medicine due to a spike in COVID-19 cases, the centre on Sunday prohibited the export of Remdesivir injection and its active pharmaceutical ingredients (API) till the situation in the country improves. ....
Several manufacturers of Remdesivir, that is being used in treatment of COVID-19, said they have ramped up production of the drug to meet its rising demand across the country. In view of increased demand for the medicine due to a spike in COVID-19 cases, the centre on Sunday prohibited the export of Remdesivir injection and its active pharmaceutical ingredients (API) till the situation in the country improves. A Zydus Cadila spokesperson said, The current spike in COVID-19 cases has led to a higher demand of Remdesivir. We are currently producing Remdesivir at three of our facilities. To cater to the demand we have ramped up our production from the earlier 5-6 lakh vials a month to 10-12 lakh vials a month, which we will scale towards 20 lakh vials a month. ....
A banner outside the lab that was sealed says it’s a free corona vaccine camp, courtesy ‘Nari Raksha Dal’ GREATER NOIDA: Phase III trials of Indian pharma major Zydus Cadila’s Covid-19 vaccine at a Ghaziabad hospital ran into controversy on Tuesday when an unrecognised private laboratory at Dadri in Greater Noida that had an understanding with the hospital was found to be administering the shots. Five people present in the lab, all employees of the hospital, according to health department officials, were arrested. Noida’s chief medical officer said the laboratory was not authorised to administer any vaccine. Officials said 19 people had taken the shots at the lab, all on Tuesday. ....